ArticleRisk analysis : an official publication of the Society for Risk Analysis2023
A novel textual track-data-based approach for estimating individual infection risk of COVID-19.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
- A novel textual track-data-based approach for estimating individual infection risk of COVID-19.Risk analysis : an official publication of the Society for Risk Analysis · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the recurrence of infectious diseases caused by coronaviruses, which pose a significant threat to human health, there is an unprecedented urgency to devise an effective method to identify and assess who is most at risk of contracting these diseases. China has successfully controlled the spread of COVID-19 through the disclosure of track data belonging to diagnosed patients. This paper proposes a novel textual track-data-based approach for individual infection risk measurement. The proposed approach is divided into three steps. First, track features are extracted from track data to build a general portrait of COVID-19 patients. Then, based on the extracted track features, we construct an infection risk indicator system to calculate the infection risk index (IRI). Finally, individuals are divided into different infection risk categories based on the IRI values. By doing so, the proposed approach can determine the risk of an individual contracting COVID-19, which facilitates the identification of high-risk populations. Thus, the proposed approach can be used for risk prevention and control of COVID-19. In the empirical analysis, we comprehensively collected 9455 pieces of track data from 20 January 2020 to 30 July 2020, covering 32 provinces/provincial municipalities in China. The empirical results show that the Chinese COVID-19 patients have six key features that indicate infection risk: place, region, close-contact person, contact manner, travel mode, and symptom. The IRI values for all 9455 patients vary from 0 to 43.19. Individuals are classified into the following five infection risk categories: low, moderate-low, moderate, moderate-high, and high risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.